TIRZEPATIDE
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide supplied by Syntide as a 20 mg research material. FDA-approved tirzepatide medicines exist, but this Syntide research vial is not an approved Mounjaro or Zepbound product.
- Product
- TIRZEPATIDE
- Quantity
- 20 mg
- Form
- Lyophilized research material - verify Syntide COA
- Presentation
- Vial
- SKU
- SA-TIRZ-20
For research use only.
Not for human or veterinary consumption.
TIRZEPATIDE / 20 mg
Tirzepatide is presented as 20 mg for laboratory research use. Product specifications and any available documentation are provided on this page.
Research context: GIPR/GLP-1R receptor pharmacology, ligand characterization, peptide chemistry, analytical identity, in vitro signaling research.
Product data
- Compound
- Tirzepatide
- Quantity
- 20 mg
- Category
- Peptide Research Reagents
- Form
- Lyophilized research material - verify Syntide COA
- Presentation
- Vial
- SKU
- SA-TIRZ-20
Quality & documentation
Available files are shown from the current documentation record for this product. Availability may vary by product or batch.
Available where provided
Documentation for this product is not currently available online. Contact support for assistance.
Order information
Shipping
Orders are processed according to the Syntide Aminos Shipping Policy.
RESEARCH USE NOTICE
Products offered by Syntide Aminos are intended solely for laboratory and research purposes. They are not intended for human or veterinary consumption and are not intended to diagnose, treat, cure or prevent any disease.
Product information provided on this website is for identification, specification and research-reference purposes only and should not be interpreted as medical advice or instructions for human use.
READ FULL RESEARCH USE DISCLAIMER
